|
Market Cap (18-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 23 June 2023, 10:42. The announcement is not marked as price sensitive, and is 42 page(s) in length and 6.12MB in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 0.944% short sold according to ASIC data. It was ranked the 235th most shorted stock on the ASX. It remains ranked 400th as of the latest reported data (05 May 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| AZD0466 Clinical Data Presented by AstraZeneca EHA Congress | 14 June 2023, 10:36 |
| Starpharma CEO to retire in 2024 | 9 June 2023, 9:32 |
You must be logged in to post a reply.
Starpharma Holdings 